Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: A randomized clinical trial

JAMA Internal Medicine

Volumn 174, Issue 3, 2014, Pages 324-333

  Williamson, Jeff D ^a   Launer, Lenore J ^b   Bryan, Nick ^c   Coker, Laura H ^a   Lazar, Ronald M ^d   Gerstein, Hertzel C ^e,f   Murray, Anne M ^g   Sullivan, Mark D ^h   Horowitz, Karen R ⁱ   Ding, Jingzhong ^b   Marcovina, Santica ^j   Lovato, Laura ^a   Lovato, James ^a   Margolis, Karen L ^k   Davatzikos, Christos ^c   Barzilay, Joshua ^l   Ginsberg, Henry N ^d   Linz, Peter E ^m   Miller, Michael E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Division of Public Health Sciences Department of Social Sciences and Health Policy Wake Forest University ^*  (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^l KAISER PERMANENTE   (United States)

^m NAVAL MEDICAL CENTER SAN DIEGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; COGNITION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPIDS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 84895726481     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.13656     Document Type: Article

References (32)

1. McBean AM, Li S, Gilbertson DT, Collins AJ. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes Care. 2004;27(10):2317-2324. (Pubitemid 39281379)
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64-74. (Pubitemid 41790697)
3. Kumar R, Anstey KJ, Cherbuin N, Wen W, Sachdev PS. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample. Am J Geriatr Psychiatry. 2008;16(12):989-998.
4. Schmidt R, Launer LJ, Nilsson LG, et al CASCADE Consortium. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes. 2004;53(3):687-692. (Pubitemid 38270638)
5. Jongen C, van der Grond J, Kappelle LJ, Biessels GJ, Viergever MA, Pluim JP; Utrecht Diabetic Encephalopathy Study Group. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia. 2007;50(7):1509-1516. (Pubitemid 46879017)
6. Guttmann CR, Benson R, Warfield SK, et al. White matter abnormalities in mobility-impaired older persons. Neurology. 2000;54(6):1277-1283. (Pubitemid 30174047)
7. van der Flier WM, van Straaten EC, Barkhof F, et al LADIS Study Group. Medial temporal lobe atrophy and white matter hyperintensities are associatedwith mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry. 2005;76(11):1497-1500. (Pubitemid 41531692)
8. Elias PK, Elias MF, D'Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study. Diabetes Care. 1997;20(9):1388-1395. (Pubitemid 27366813)
9. DeKosky ST. Statin therapy in the treatment of Alzheimer disease: what is the rationale? Am J Med. 2005;118(12A)(suppl 12A):48-53.
10. Williamson JD, Miller ME, Bryan RN, et al ACCORD Study Group. The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol. 2007;99(12A):112i-122i.
11. Buse JB, Bigger JT, Byington RP, et al ACCORD Study Group. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007;99(12A):21i-33i.
12. Launer LJ, Miller ME, Williamson JD, et al ACCORD MIND Investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10(11):969-977.
13. Gerstein HC, Miller ME, Byington RP, et al Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559. (Pubitemid 351831356)
14. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes: systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460-2469. (Pubitemid 41738208)
15. Coker LH, Shumaker SA. Type 2 diabetes mellitus and cognition: an understudied issue inwomen's health. J Psychosom Res. 2003;54(2):129-139. (Pubitemid 36292425)
16. Wechsler D, ed. Wechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corp; 1988.
17. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. New York, NY: Oxford University Press; 2004.
18. Houx PJ, Jolles J, Vreeling FW. Stroop interference: aging effects assessed with the Stroop Color-Word Test. Exp Aging Res. 1993;19(3):209-224. (Pubitemid 23308505)
19. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
20. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. (Pubitemid 32823891)
21. Goldszal AF, Davatzikos C, Pham DL, Yan MX, Bryan RN, Resnick SM. An image-processing system for qualitative and quantitative volumetric analysis of brain images. J Comput Assist Tomogr. 1998;22(5):827-837. (Pubitemid 28457751)
22. Lao Z, Shen D, Liu D, et al. Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol. 2008;15(3):300-313. (Pubitemid 351246730)
23. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
24. Molenberghs G, Kenward M, eds. Missing Data in Clinical Studies. Chichester, England: Wiley & Sons; 2007.
25. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine: reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189-2194.
26. Ginsberg HN, Elam MB, Lovato LC, et al ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1563-1574.
27. Cushman WC, Evans GW, Byington RP, et al ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-1585.
28. Gerstein HC, Miller ME, Genuth S, et al ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818-828.
29. Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation. 2011;123(3):266-273.
30. de Leeuw F-E, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002;125(pt 4):765-772. (Pubitemid 34279772)
31. Launer LJ. Diabetes and brain aging: epidemiologic evidence. Curr Diab Rep. 2005;5(1):59-63. (Pubitemid 40277802)
32. Bateman RJ, Xiong C, Benzinger TL, et al Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367(9):795-804.